1 hr ago | AmericanBankingNews.com
GlaxoSmithKline's "Buy" Rating Reaffirmed at Societe Generale
's stock had its "buy" rating restated by equities researchers at Societe Generale in a report issued on Thursday, Stock Ratings Network.com reports.
5 hrs ago | The Standard
GlaxoSmithKline flu jab Pandemrix linked to narcolepsy, study finds...
Finnish researchers unveiled new data to link the Pandemrix flu vaccine made by British drug company GlaxoSmithKline to a higher risk of the sleeping disorder narcolepsy in adults.
7 hrs ago | Pharmaceutical Technology
US Government Signs Deal with GSK to Develop Antibiotics
GlaxoSmithKline and the Biomedical Advanced Research and Development Authority , part of the United States Department of Health and Human Services , have agreed to a collaboration that will support the development of several antibiotics to fight antibiotic resistance and bioterrorism, GSK announced in a press release .
11 hrs ago | Forbes.com
Steven Nissen: The Hidden Agenda Behind The FDA's New Avandia Hearings
This post was written by Steven E. Nissen MD, the Chairman of the Department of Cardiovascular Medicine at the Cleveland Clinic.
15 hrs ago | BioSpace
GlaxoSmithKline Flu Shot May Raise Adult Narcolepsy Risk
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! GlaxoSmithKline Plc's H1N1 pandemic flu shot may put adults at higher risk of developing narcolepsy, not only children as previous studies found, Finland's National Institute for Health and Welfare said on Thursday.
18 hrs ago | The New Zealand Herald
NZ running low on chickenpox vaccines
New Zealand is running low on chickenpox vaccines as more parents seek to have their children immunised and as winter approaches.
23 hrs ago | The Press On-Line
Chickenpox vaccine supplies run out
Drug company GlaxoSmithKline has notified medical centres throughout the country that the Varilrix vaccine would be temporarily out of stock for the next few weeks.
GlaxoSmithKline Stock Rating Reaffirmed by BNP Paribas
's stock had its "underperform" rating restated by analysts at BNP Paribas in a research report issued to clients and investors on Wednesday, ARN reports.
Aspen & Local CMOs to Benefit from GSK's Aus Packaging Plant Closure
GlaxoSmithKline says some manufacturing from the shuttering of an Australian packaging site will be picked up by Aspen and local third-party contractors.
GlaxoSmithKline Says Lowering Prices in China Caused Higher Sales
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! by Richard Daverman, PhD May 21, 2013 -- Want to increase revenues in China? You might try lowering prices.
Olivia Walker and Rod Ashton working on the Ventolin production line at GlaxoSmithKline pharmaceutical plant at Boronia.
U.S. government taps GlaxoSmithKline for new antibiotics
The U.S. government has signed an antibiotics development deal worth up to $200 million with GlaxoSmithKline to tackle the dual threats of drug resistance and bioterrorism.
What Are the City's Expectations for GlaxoSmithKline's Profits?
When weighing a potential investment, it's useful to look forward rather than backwards.
GlaxoSmithKline Receives Buy Rating from Cenkos Securities Ltd
's stock had its "buy" rating reaffirmed by Cenkos Securities Ltd in a research note issued on Monday, Analyst Ratings Network reports.
Market Report: GlaxoSmithKline tipped for Danish drug deal
Ever since GSK in December 2006 broke a then industry record by licensing a drug for leukaemia from Genmab for 1.6bn, taking a 10 per cent stake in the process, the pharmaceutical world has expected GSK to one day launch a full-scale cash offer.
MSCI India adds Wockhardt, OIL, GSK Consumer, Apollo Hospitals
Apollo Hospitals, Oil India, Wockhardt and GlaxoSmithKline Consumer Healthcare have been added to the MSCI India index.
Theravance and Elan Enter $1 Billion Royalty Participation Agreement
Theravance and Elan announced in a press release that Elan will purchase a participation interest in potential future royalty payments related to four respiratory programs partnered with GlaxoSmithKline : RELVAR ELLIPTA/BREO ELLIPTA , ANORO ELLIPTA , MABA monotherapy , and vilanterol monotherapy.
On the morning of Aug. 18, 2004, Dinesh Thakur hurried to a hastily arranged meeting with his boss at the gleaming offices of Ranbaxy Laboratories in Gurgaon, India, 20 miles south of New Delhi.
OncoMed Pharmaceuticals Initiates Phase 1b/2 Clinical Trial of...
OncoMed Pharmaceuticals, Inc., a clinical-stage company developing novel therapeutics that target cancer stem cells , or tumor-initiating cells, today announced clinical progress with its Anti-Notch2/3 product candidate, which will trigger an $8 million milestone payment from the company's strategic collaborator GlaxoSmithKline .
GlaxoSmithKline's "Buy" Rating Reaffirmed at TheStreet
's stock had its "buy" rating reiterated by equities research analysts at TheStreet in a research note issued to investors on Tuesday, AnalystRatingsNetwork reports.